ATA, Inc. (NASDAQ:ATAI) shares decreased -1.63% in last trading session and ended the day at $3.61. ATAI Gross Margin is 50.70% and its has a return on assets of 5.30%. ATA, Inc. (NASDAQ:ATAI) quarterly performance is 4.34%.
ATA Inc. (NASDAQ: ATAI), a leading provider of advanced testing technologies and testing-related services in China, announced that it will release its financial results for the fiscal second quarter ended September 30, 2015, after the close of the stock market on Wednesday, November 11, 2015. The Company will discuss those results in a conference call at 8 a.m. ET on Thursday, November 12, 2015.
Ignyta, Inc. (NASDAQ:RXDX) ended the last trading day at $10.14. Company weekly volatility is calculated as 11.16% and price to cash ratio as 2.76. Ignyta, Inc. (NASDAQ:RXDX) showed a weekly performance of 1.20%.
Ignyta, Inc. (NASDAQ: RXDX), announced the acceptance of four abstracts for poster presentations at the 27th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Boston, Massachusetts. The presentations relate to the company’s three clinical-stage product candidates, entrectinib, RXDX-105 and RXDX-107, and will be made on November 6-8, 2015.
On 29 October, Calix Inc. (NYSE:CALX) shares decreased -1.56% and was closed at $8.86. CALX EPS growth in last 5 year was 10.70%. Calix Inc. (NYSE:CALX) year to date (YTD) performance is -11.58%.
Calix, Inc. (NYSE: CALX) reported Q3 EPS of $0.16, $0.08 better than the analyst estimate of $0.08. Revenue for the quarter came in at $12.3 million versus the consensus estimate of $109.14 million.
On Assignment Inc. (NYSE:ASGN) shares increased 7.04% in last trading session and ended the day at $44.39. ASGN Gross Margin is 32.20% and its has a return on assets of 6.90%. On Assignment Inc. (NYSE:ASGN) quarterly performance is 15.84%.
On Assignment Inc. (NYSE:ASGN) reported Revenues were $572.1 million; up 29.3 percent year-over-year (30.3 percent on a constant currency basis). Constant currency revenues and growth rates for the quarter were calculated using the foreign currency exchange rates from the same period in the prior year.
Alkermes plc (NASDAQ:ALKS) caters to the Healthcare space. It has a net profit margin of -13.30% and weekly performance is 16.97%. On the last day of trading company shares ended up at $70.99. Alkermes plc (NASDAQ:ALKS) distance from 50-day simple moving average (SMA50) is 7.52%.
Alkermes PLC (NASDAQ:ALKS) on Thursday reported a loss of $81 million in its third quarter. The Dublin-based company said it had a loss of 54 cents per share. Losses, adjusted for stock option expense and amortization costs, were 18 cents per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.
Leave a Reply